Skip to content
healthcare.dev

Naproxen Sodium

NDC 45802-490, Naproxen Sodium, tablet, film coated, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-490
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA074661
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-490 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
45802-490-75458020490751 BOTTLE in 1 CARTON (45802-490-75) / 90 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802049075

    GET /v1/drugs/nadac/45802049075

Use it

Look up 45802-490 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-490 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-490. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.